It's not my model. It was developed by Statistics Canada in partnership with the Canadian Partnership Against Cancer. It's a wonderful model, and it is available for multiple cancers. It's been validated against empirical data, against actual measurements in the public. We compare it to the U.S. models, of which there are five. Actually, one of the models is from the Netherlands. We always cross-compare models, and they tend to agree with each other, which is great. That gives us more confidence in their validity.
